Details of the Drug

General Information of Drug (ID: DMY9JA5)

Drug Name

SYNB-1934

Indication

Disease Entry	ICD 11	Status	REF
Phenylketonuria	5C50.0	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05764239) A Phase 3, Double-blind, Placebo-controlled, Randomized Withdrawal Study to Evaluate the Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3). U.S.National Institutes of Health.